ישראל -
עברית -
Ministry of Health
דיאנה 35
bayer israel ltd - cyproterone acetate; ethinylestradiol - טבליה - ethinylestradiol 35 mcg; cyproterone acetate 2 mg - cyproterone and estrogen - cyproterone and estrogen - treatment of moderate to severe acne related to androgen-sensitivity (with or without seborrhoea) and/or hirsutism, in women of reproductive age. for the treatment of acne, diane-35 should only be used after topical therapy or systemic antibiotic treatments have failed.
ישראל -
עברית -
Ministry of Health
דיאנה 35
bayer israel ltd - cyproterone acetate; ethinylestradiol - טבליה - ethinylestradiol 35 mcg; cyproterone acetate 2 mg - cyproterone and estrogen - cyproterone and estrogen - treatment of moderate to severe acne related to androgen-sensitivity (with or without seborrhoea) and/or hirsutism, in women of reproductive age. for the treatment of acne, diane-35 should only be used after topical therapy or systemic antibiotic treatments have failed.
ישראל -
עברית -
Ministry of Health
אסטל 35
taro international ltd, israel - cyproterone acetate; ethinylestradiol - טבליה - ethinylestradiol 0.035 mg; cyproterone acetate 2 mg - for the treatment of signs of androgenization in women such as pronounced forms of acne, androgenic alopecia and mild forms of hirsutism.
ישראל -
עברית -
Ministry of Health
אסטל 35 טבליות
taro international ltd, israel - cyproterone acetate; ethinylestradiol - טבליה - ethinylestradiol 0.035 mg; cyproterone acetate 2 mg
ישראל -
עברית -
Ministry of Health
איה נטורל חמאת 35+ וניל-לצוואר מחשוף ופנים
איה נטורל בעמ - לחות לעור
ישראל -
עברית -
Ministry of Health
ג'ייד גלייד אנד וור גלוס סטיק מס' 351
דניה קוסמטיקס בעמ - איפור שפתיים
ישראל -
עברית -
Ministry of Health
פברזיים 35 מג
sanofi israel ltd - agalsidase beta - אבקה להכנת תמיסה מרוכזת לעירוי - agalsidase beta 35 mg/vial - agalsidase beta - agalsidase beta - fabrazyme is indicated for use as long-term enzyme replacement therapy in patients with a confirmed diagnosis of fabry disease. (alfa - galactosidase a deficiency).
ישראל -
עברית -
Ministry of Health
ריזדרונט טבע 35 מג
abic marketing ltd, israel - risedronic acid as sodium - טבליה - risedronic acid as sodium 35 mg - risedronic acid - risedronic acid - treatment of postmenopausal osteoporosis to reduce the risk of vertebral fractures. treatment of established postmenopausal osteoporosis to reduce the risk of hip fractures. prevention of osteoporosis in postmenopausal women with increased risk of osteoporosis. treatment of osteoporosis in men at high risk of fracture.